安科生物:公司曲妥珠单抗正在按药审中心发补要求补充相关资料
安科生物3月31日在投资者互动平台表示,我公司曲妥珠单抗正在按药审中心发补要求补充相关资料,目前相关资料工作进展顺利,公司尽快将补充资料报送药审中心进行发补审评。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
ChatGPT banned in Italy by regulators over data privacy concerns By
U.S. stocks are rising after inflation data boosts hopes for Fed pause By
Related News
![](/images/page_blank@2x.png)